Psychiatr. pro Praxi, 2006; 2: 64-65

Adverse events and side effects of psychopharmacotherapy

MUDr. Luboš Janů Ph.D, MUDr. Sylva Racková
Psychiatrická klinika FN a LF UK v Plzni

There is a strong potential for therapeutic action in psychotropic medication except main indication. The term side-effects doesn´t overlap with adverse events. Side-effects can have an advantage for special subpopulation of patiens. We clarify this terms and describe the common type of side-effects in therapeutical practise.

Keywords: Key words: adverse events, side-effects, indications, antipsychotics, antidepressants, anxiolytics.

Published: April 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janů L, Racková S. Adverse events and side effects of psychopharmacotherapy. Psychiatr. praxi. 2006;7(2):64-65.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baštecký J, Šavlík J, Šimek J: Psychosomatická medicína. Praha, Grada, 1993.
    2. Bomholt SF, Mikkelsen JD, Blackburn-Munro G: Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology. 2005 Feb; 48(2): 252-63. Go to original source... Go to PubMed...
    3. Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G: Off-label indications for atypical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry. 2004 Feb 18; 3(1): 4. Go to original source... Go to PubMed...
    4. Galynker I, Khan A, Grebchenko Y, Ten A, Malaya L, Yanowitch P, Cohen LJ: Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression. J Clin Psychiatry. 2005 Apr; 66(4): 544. Go to original source... Go to PubMed...
    5. Janů L: Thiethylperazine-induced akathisia. Presented at XIII WPA World Congress of Psychiatry. Cairo September 2005.
    6. Luisi AF, Pawasauskas JE: Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy. 2003 Sep; 23(9): 1131-40. Go to original source... Go to PubMed...
    7. Mitwally MF, Kahn LS, Halbreich U: Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices. Expert Opin Pharmacother. 2002 Nov; 3(11): 1577-90. Go to original source... Go to PubMed...
    8. Roose SP: Compliance: the impact of adverse events and tolerability on the physician's treatment decisions. Eur Neuropsychopharmacol. 2003 Sep; 13 Suppl 3: S85-92. Go to original source... Go to PubMed...
    9. Saarto T, Wiffen P: Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005 Jul 20; (3): CD005454. Go to original source... Go to PubMed...
    10. Swenson JR, O'Connor CM, Barton D, Van Zyl LT, Swedberg K, Forman LM, Gaffney M, Glassman AH; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group.: Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol. 2003 Dec 1; 92(11): 1271-6. Go to original source... Go to PubMed...
    11. www.sukl.cz

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.